	US 12,280,069 B2
	Methods of using human milk oligosaccharides for improving airway respiratory health
Rachael Buck, Gahanna, OH (US); Geralyn O. Duska-Mcewen, Columbus, OH (US); and Steven R. Davis, Columbus, OH (US)
Assigned to ABBOTT LABORATORIES, Abbott Park, IL (US)
Filed by ABBOTT LABORATORIES, Abbott Park, IL (US)
Filed on Dec. 27, 2021, as Appl. No. 17/562,327.
Application 17/562,327 is a continuation of application No. 14/456,221, filed on Aug. 11, 2014, granted, now 11,207,335.
Application 14/456,221 is a continuation of application No. 13/335,433, filed on Dec. 22, 2011, granted, now 8,802,650, issued on Aug. 12, 2014.
Claims priority of provisional application 61/527,851, filed on Aug. 26, 2011.
Claims priority of provisional application 61/428,860, filed on Dec. 31, 2010.
Prior Publication US 2022/0117984 A1, Apr. 21, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/702 (2006.01); A23C 9/20 (2006.01); A23L 33/00 (2016.01); A61K 31/05 (2006.01); A61K 31/716 (2006.01)

CPC A61K 31/702 (2013.01) [A23C 9/206 (2013.01); A23L 33/40 (2016.08); A61K 31/05 (2013.01); A61K 31/716 (2013.01); A23V 2002/00 (2013.01)]

17 Claims

1. A method of treating or preventing a respiratory syncytial virus (RSV) in a human subject, the method comprising administering to the subject a nutritional composition comprising (a) one or more carotenoids comprising at least one of lutein, lycopene, zeaxanthin, and beta-carotene, in which the total amount of the one or more carotenoids in the nutritional composition is 1 mcg/mL or less, and (b) from about 0.001 mg/ml to about 20 mg/mL of the human milk oligosaccharides 2′-fucosyllactose.